Literature DB >> 16099219

Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues.

Allan L Goldstein1, Ewald Hannappel, Hynda K Kleinman.   

Abstract

Here, we review the biochemical and molecular properties of thymosin beta(4) (Tbeta(4)), the major actin-sequestering molecule in eukaryotic cells, and its key role in dermal- and corneal-wound healing. Tbeta(4) has several, novel, potential clinical applications in the repair and remodeling of ulcerated tissues and solid organs following hypoxic injuries, such as myocardial infarction and stroke. It might also have important repair functions in the pathophysiologic sequelae that are associated with actin toxicity and with septic shock, such as respiratory distress syndrome, multi-organ failure and severe tissue trauma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099219     DOI: 10.1016/j.molmed.2005.07.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  70 in total

1.  Thymosin beta4: a candidate for treatment of stroke?

Authors:  Daniel C Morris; Michael Chopp; Li Zhang; Zheng G Zhang
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

2.  Thymosin-β4 (Tβ4) blunts PDGF-dependent phosphorylation and binding of AKT to actin in hepatic stellate cells.

Authors:  Karina Reyes-Gordillo; Ruchi Shah; Anastas Popratiloff; Sidney Fu; Anna Hindle; Frederick Brody; Marcos Rojkind
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 3.  Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?

Authors:  Julia S Gelman; Lloyd D Fricker
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

4.  Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.

Authors:  D C Morris; M Chopp; L Zhang; M Lu; Z G Zhang
Journal:  Neuroscience       Date:  2010-08-25       Impact factor: 3.590

Review 5.  Investigational agents for treatment of traumatic brain injury.

Authors:  Ye Xiong; Yanlu Zhang; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Investig Drugs       Date:  2015-03-01       Impact factor: 6.206

6.  Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

Authors:  Gabriel Sosne; Ping Qiu; Patricia L Christopherson; Michelle Kurpakus Wheater
Journal:  Exp Eye Res       Date:  2007-01-23       Impact factor: 3.467

7.  Novel endogenous peptide agonists of cannabinoid receptors.

Authors:  Ivone Gomes; Julia S Grushko; Urszula Golebiewska; Sascha Hoogendoorn; Achla Gupta; Andrea S Heimann; Emer S Ferro; Suzanne Scarlata; Lloyd D Fricker; Lakshmi A Devi
Journal:  FASEB J       Date:  2009-04-20       Impact factor: 5.191

8.  Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.

Authors:  Maureen S Riedl; Patrick D Braun; Kelley F Kitto; Samuel A Roiko; Lorraine B Anderson; Christopher N Honda; Carolyn A Fairbanks; Lucy Vulchanova
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

9.  Thymosin β4 for the treatment of acute stroke in aged rats.

Authors:  Daniel C Morris; Wing Lee Cheung; Richard Loi; Talan Zhang; Mei Lu; Zheng G Zhang; Michael Chopp
Journal:  Neurosci Lett       Date:  2017-08-31       Impact factor: 3.046

10.  Exogenous thymosin beta4 prevents apoptosis in human intervertebral annulus cells in vitro.

Authors:  H Tapp; R Deepe; J A Ingram; E G Yarmola; M R Bubb; E N Hanley; H E Gruber
Journal:  Biotech Histochem       Date:  2009-12       Impact factor: 1.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.